DRUG PATENTS COME UNDER FIRE AT AIDS CONFERENCE
BALI, (Aug. 12, 2009) IPS/GIN – Pharmaceutical firms have developed
drugs that have lengthened lives and cut death rates from HIV and
AIDS, but their financial clout in no way overrides their social
responsibility in fighting the pandemic, a key advocate argued at
an Asian conference on AIDS Wednesday.
At the 9th International Conference on AIDS in Asia and the Pacific
(ICAAP), Javed Jabbar, a former senator and minister from Pakistan,
called on governments and communities to remind drug firms of the
fundamental difference between owning patents on goods – such as
designer items or mobile phones – and life-saving HIV drugs.
Comments